Evidence map›Paper›PMID 25823013›Full record

ArticlePloS one2015

A system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter.

Christopher B Chambers, William P Halford, Joshua Geltz, Olga Villamizar, Jeffrey Gross, Alison Embalabala, Edward Gershburg, Andrew Wilber

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Christopher B ChambersDepartment of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, Illinois, United States of America.
William P HalfordDepartment of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, Illinois, United States of America.
Joshua GeltzDepartment of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, Illinois, United States of America.
Olga VillamizarDepartment of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, Illinois, United States of America.
Jeffrey GrossDepartment of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, Illinois, United States of America.
Alison EmbalabalaDepartment of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, Illinois, United States of America.
Edward GershburgDepartment of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, Illinois, United States of America.
Andrew WilberDepartment of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, Illinois, United States of America.
Southern Illinois University School of Medicine · US

Funding

FACS Aria II for Flow Cytometry Core FacilityS10RR025674 · NCRR · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI LIBERATI, TERESA · 2010 to 2010
$473k
Renal Cell Tumor-Mediated Trans-differentiation of Natural Killer CellsR15CA173657 · NCI · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI WILBER, ANDREW CHRISTROPHER · 2013 to 2013
$375k
NCI NIH HHS R15 CA173657NCRR NIH HHS S10 RR025674NCRR NIH HHS S10RR025674
6 · The paper itself

Abstract

Expression systems used to study the biological function of a gene of interest can have limited utility due to three major factors: i) weak or heterogeneous gene expression; ii) poorly controlled gene expression; and iii) low efficiencies of stable integration and persistent expression. We envisioned that the ideal system should be tightly controlled and coupled with the ability to efficiently create and identify stable cell lines. Herein, we describe a system based upon a bidirectional Herpes simplex virus type 1 promoter that is naturally responsive to the VP16 transactivator and modified to permit tetracycline-regulated transcription on one side while maintaining constitutive activity on the other side. Incorporation of this element into the Sleeping Beauty transposon resulted in a novel bidirectional system with the capacity for high-efficiency stable integration. Using this system, we created stable cell lines in which expression of a gene of interest was tightly and uniformly controlled across a broad range of levels via a novel combination of doxycycline-sensitive de-repression and VP16-mediated sequence-specific induction. The unique characteristics of this system address major limitations of current methods and provide an excellent strategy to investigate the effects of gene dosing in mammalian models.

Indexed as

Cell LineCell Line, TumorDNA Transposable ElementsDoxycyclineGene ExpressionGene Expression Regulation, ViralHEK293 CellsHeLa CellsHerpesvirus 1, HumanHumansPromoter Regions, GeneticTetracyclineTrans-ActivatorsTranscription, GeneticDNA Transposable ElementsDoxycyclineTetracyclineTrans-Activators

Identifiers

PMID25823013
PMCPMC4378986
OpenAlexW2035485651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.